REAL-WORLD EFFICACY AND SAFETY OF BOCEPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

被引：1
|
作者：
Moog, G. [1 ]
Schober, A. [2 ]
Antoni, C. [3 ]
Bruch, H. R. [4 ]
Herrmann, A. [5 ]
John, C. [6 ]
Steffens, H.
Leuschner, M. [7 ]
Spengler, U. [8 ]
Moeller, B. [6 ,9 ]
Isernhagen, K.
Hueppe, D. [10 ]
Alshuth, U. [11 ]
Mauss, S. [12 ]
机构：
[1] Ctr Gastroenterol, Kassel, Germany
[2] Ctr Gastroenterol, Gottingen, Germany
[3] Univ Med Mannheim, Med Univ Klin 2, Mannheim, Germany
[4] Ctr Gastroenterol, Bonn, Germany
[5] Univ Basel Hosp, Dept Internal Med 2, Jena, Germany
[6] Ctr Gastroenterol, Berlin, Germany
[7] Ctr Hepatol, Offenbach, Germany
[8] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany
[9] Ctr Liver, Berlin, Germany
[10] Ctr Gastroenterol, Herne, Germany
[11] Roche Pharma AG, Virol, Grenzach Wyhlen, Germany
[12] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60877-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
875
引用
收藏
页码：S359 / S360
页数：2
相关论文
共 50 条
  • [31] Interim analysis from TRIC-1 a study of metformin with peginterferon alfa-2a and ribavirin in treatment naive genotype 1 chronic hepatitis C with insulin resistance
    Romero-Gomez, M.
    Diago, M.
    Andrade, R. J.
    Calleja, J. L.
    Salmeron, J.
    Fernandez-Rodriguez, C. M.
    Sola, R.
    Herrerias, J. M.
    Garcia-Samaniego, J.
    Moreno-Otero, R.
    Olveira, A.
    Nunez, O.
    De la Mata, M.
    Jorquera, E.
    Morillas, R. M.
    Dalmau, B.
    Martin-Vivaldi, R.
    Arenas-Ruiz, J. I.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S375 - S375
  • [32] EFFICACY AND SAFETY OF TMC435 IN COMBINATION WITH PEGINTERFERON α-2A AND RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 HCV PATIENTS: 24-WEEK INTERIM RESULTS FROM THE PILLAR STUDY
    Fried, Michael W.
    Buti, Maria
    Dore, Gregory J.
    Ferenci, Peter
    Jacobson, Ira
    Marcellin, Patrick
    Zeuzem, Stefan
    Lenz, Oliver
    Peeters, Monika
    Sekar, Vanitha J.
    De Smedt, Goedele
    [J]. HEPATOLOGY, 2010, 52 (04) : 403A - 404A
  • [33] EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
    Marcellin, P.
    Vierling, J. M.
    Alric, L.
    Pirisi, M.
    Tran, A.
    Albrecht, J. K.
    Brass, C. A.
    Boparai, N.
    Sniukiene, V.
    Burroughs, M.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S184 - S184
  • [34] Efficacy among North American and European HCV genotype-1 treatment-naive and previous non-responders and relapsers to peginterferon/ribavirin when treated with boceprevir plus peginterferon alfa-2b/ribavirin
    Bognar, F.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 97 - 98
  • [35] Subgroup analysis of the non-interventional study VIVALDI: Agomelatine in treatment-naive patients, in combination therapy and aft er treatment switch
    Laux, Gerd
    Huttner, Nadja A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2014, 18 (02) : 86 - 96
  • [36] REAL-WORLD EFFECTIVENESS AND SAFETY OF APREMILAST IN GERMAN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF AN ONGOING MULTICENTRE, PROSPECTIVE, NON-INTERVENTIONAL STUDY
    Wollenhaupt, J.
    Klopsch, T.
    Strothmeyer, H.
    Morys, S.
    Bach, C.
    Nunez-Gomez, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1590 - 1590
  • [37] Efficacy Among North American and European HCV Genotype-1 Treatment-NaiVE and Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin
    Marcellin, Patrick
    Vierling, John M.
    Alric, Laurent
    Pirisi, Mario
    Tran, Albert
    Albrecht, Janice K.
    Brass, Clifford A.
    Boparai, Navdeep
    Sniukiene, Vilma
    Burroughs, Margaret
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S945 - S945
  • [38] Virologic responses to peginterferon alfa-2a/ribavirin in treatment-naive Latino vs non-Latino Caucasians infected with HCV genotype 1: The LATINO study
    Rodriguez-Torres, M.
    Jeffers, L. J.
    Sheikh, M. Y.
    Rossaro, L.
    Ankoma-Sey, V.
    Hamzeh, F. M.
    Martin, P.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S311 - S311
  • [39] Safety and efficacy of triple therapy containing boceprevir (BOC) or telaprevir (TVR) plus peginterferon alfa-2a / ribavirin in patients with advanced fibrosis or cirrhosis in real-life setting
    Mauss, Stefan
    Schober, Andreas
    John, Christine
    Lutz, Thomas
    Moog, Gero
    Bruch, Harald-Robert
    Teuber, Gerlinde
    Christensen, Stefan
    Heyne, Renate
    Pape, Stefan
    Naumann, Uwe
    Roessle, Martin
    Schiffelholz, Willi
    Loehr, Hanns-Friedrich F.
    Alshuth, Ulrich
    Hueppe, Dietrich
    [J]. HEPATOLOGY, 2013, 58 : 1098A - 1099A
  • [40] Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO
    Gutzmer, R.
    Weichenthal, M.
    Eigentler, T.
    Grimmelmann, I.
    Sickmann, T.
    Zimmer, L.
    Livingstone, E.
    Ugurel, S.
    Utikal, J. S.
    Muller, V.
    Goppner, D.
    Herbst, R.
    Kreuter, A.
    Pfohler, C.
    Hollburg, W.
    Loquai, C.
    Kahler, K.
    Mohr, P.
    Schadendorf, D.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 18 - 19
12345